Organon (Shanghai) Pharmaceutical Technology: Public disease education on Androgenetic Alopecia

Organon's Propecia, a prescription drug, launched a campaign in China to build target audiences' perception that hair loss is a kind of disease that needs scientific treatment.

Background & Challenges

In 2019, more than 250 million people in China were reported to be experiencing hair loss, making up one out of every six people in the country.1

One of the most common causes of hair loss is the disease Androgenetic alopecia...

Not a subscriber?

Schedule your live demo with our team today